Long-limb length difference had no effect on outcomes of laparoscopic Roux-en-Y gastric bypass surgery for obese Chinese patients with type 2 diabetes mellitus: A CONSORT compliant article

Medicine
Wei YanNeng-wei Zhang

Abstract

Bariatric surgery is effective in treating different components of metabolic syndrome including obesity, type 2 diabetes mellitus (T2DM), and hyperlipidemia. But there is no consensus on the ideal biliopancreatic and Roux limb length. This study aimed to explore the effect of biliopancreatic limb and Roux limb lengths during laparoscopic Roux-en-Y gastric bypass (LRYGB) procedures on weight loss and T2DM control.We studied the clinical records of 58 patients with metabolic syndrome, T2DM, and body mass index (BMI) 32 to 50 kg/m who underwent LRYGB in our hospital. The short limb group (Group A) underwent LRYGB with a limb length of 160 to 200 cm (n = 31) and the long limb group (Group B) underwent LRYGB with a limb length of 210 to 240 cm (n = 27) were compared.The occurrence of acute or chronic internal hernia in Group B was higher than that in Group A (P = .026). Twelve months after surgery, patients from the 2 groups were also observed with reduction in BMI, percent excess weight loss (EWL), preoperative FPG, and HbA1c as compared with these indicators before surgery. However, the differences of these indicators between 2 groups were not significant at the time point of before and 3, 6, 12 months after surgery.LRYGB had sign...Continue Reading

References

Aug 24, 2006·Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery·Atul K MadanDavid S Tichansky
Dec 8, 2007·Obesity Surgery·Ruxandra CiovicaGuilherme M Campos
Jun 10, 2008·Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery·Jose S PinheiroRicardo Cohen
Nov 11, 2008·Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery·John J Gleysteen
Jan 6, 2009·Diabetes Care·UNKNOWN American Diabetes Association
Nov 4, 2009·Obesity Surgery·Henry Buchwald, Danette M Oien
Mar 26, 2010·The New England Journal of Medicine·Wenying YangUNKNOWN China National Diabetes and Metabolic Disorders Study Group
Jul 10, 2010·Diabetes Technology & Therapeutics·Radha NandagopalKristina I Rother
Aug 4, 2010·Obesity Surgery·Dimitrios StefanidisKeith S Gersin
Nov 30, 2010·Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery·M Logan RawlinsJohn P Maguire
Apr 23, 2011·Obesity Surgery·Mário NoraMariana P Monteiro
Aug 3, 2011·Current Hypertension Reports·Annie Ferland, Robert H Eckel
Dec 6, 2011·Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery·Yu-Hsi KaoChih-Kun Huang
Feb 22, 2012·Surgical Endoscopy·Monika Proczko-MarkuszewskaZbigniew Sledziński
Oct 6, 2014·Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery·Israel AbellanPascual Parrilla
Jul 31, 2016·The Surgical Clinics of North America·Lindsay BerbigliaAdrian G Dan

❮ Previous
Next ❯

Methods Mentioned

BETA
gastric bypass

Software Mentioned

SPSS

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.